Anaconda支架系统FEVAR术后靶血管不稳定的几何分析
本研究回顾性分析101例使用Anaconda定制开窗支架行FEVAR的患者共359条靶血管,技术成功率97%,30天主要不良事件率21.7%且无死亡。中位随访36个月靶血管不稳定发生率为7.8%,多因素分析显示密封长度增加和支架突入主动脉≥7 mm是内脏血管靶血管不稳定的独立预测因素。
要点
- Anaconda开窗支架FEVAR技术成功率高,中远期靶血管稳定性可接受。
- 支架突入主动脉≥7 mm与内脏及肾动脉靶血管不稳定/闭塞独立相关。
- 密封长度增加是内脏血管靶血管不稳定的独立预测因素。
核心结论
- 使用Anaconda定制开窗支架行FEVAR技术成功率高且中期免于靶血管不稳定。
- 支架突入主动脉过长和密封长度增加对靶血管不稳定产生不利影响。
- 优化桥接支架几何形态可能降低再干预率并改善复杂主动脉修复结局。
研究设计与样本
- 回顾性单中心研究纳入2013年9月至2023年12月连续接受Anaconda开窗支架FEVAR的全部患者。
- 共分析101例患者359条靶血管,使用Aquarius iNtuition软件评估术前术后血管几何形态。
- 主要终点为靶血管不稳定(闭塞、狭窄、I/III型内漏或再干预)和12个月免于再干预,次要终点为术中技术成功和30天主要不良事件率。
主要发现
- 技术成功率为97%,30天主要不良事件率为21.7%,无死亡。
- 中位随访36个月(IQR 22-55个月)靶血管不稳定发生率为7.8%,其中IIIc型内漏4.5%、狭窄1.4%、Ic型内漏1.9%。
- 多因素分析显示密封长度增加(OR=1.080,95%CI 1.002-1.164,p=0.044)和支架突入主动脉≥7 mm(OR=1.406,95%CI 1.067-1.852,p=0.015)是内脏血管靶血管不稳定的独立预测因素。
- 肾动脉靶血管中支架突入≥7 mm与闭塞显著相关(OR=1.284,95%CI 1.019-1.618,p=0.034)。
- 以死亡为竞争风险靶血管不稳定的累积发生率在1、2、5年分别为3.1%、3.6%、5.9%。
临床怎么用
- 术中应精确控制桥接支架突入主动脉的长度,避免≥7 mm以减少靶血管不稳定。
- 计划与释放阶段需关注密封长度配置,将其作为可优化的几何参数。
- 对内脏和肾动脉靶血管应个体化评估支架几何形态以降低再干预风险。
局限性
- 本研究为回顾性单中心设计。
- 原文未报告其他局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Fenestrated endovascular aneurysm repair (FEVAR) has emerged as a standard treatment for complex abdominal and thoracoabdominal aortic aneurysms (CAAAs/TAAAs), yet target vessel instability (TVI) remains a concern. This study evaluates mid-term outcomes and anatomical predictors of TVI following FEVAR using the Anaconda custom-made fenestrated stent-graft system (Terumo Aortic, Inchinnan, Scotland, UK). METHODS: A retrospective single-center study included all consecutive patients treated with FEVAR using Anaconda stent-graft between September 2013 and December 2023. Preoperative and postoperative vessel geometry was assessed using Aquarius iNtuition software (TeraRecon, Foster City, CA). Primary endpoints were TVI (occlusion, stenosis, type I/III endoleak, or re-intervention) and freedom from re-intervention at 12 months. Secondary endpoints were intraoperative technical success and 30-day major adverse events (MAEs) rate. RESULTS: A total of 101 patients with 359 target vessels were analyzed. Technical success was 97%. The 30-day MAE rate was 21.7%, with no mortality. Target vessel instability occurred in 7.8% (4.5% type IIIc endoleak, 1.4% stenosis, and 1.9% type Ic endoleak) during a median follow-up of 36 months (interquartile range [IQR]=22-55 months). Multivariate analysis identified increased sealing length (odds ratio [OR]=1.080, 95% confidence interval [CI]: 1.002, 1.164, p=0.044) and intra-aortic stent protrusion≥7 mm (OR=1.406, 95% CI: 1.067, 1.852, p=0.015) as independent predictors of TVI in visceral vessels. In renal target vessels, protrusion ≥ 7 mm (OR=1.284, 95% CI: 1.019, 1.618, p=0.034) was significantly associated with occlusion. Cumulative incidence of TVI with death as competing risk was 3.1%, 3.6%%, and 5.9% at 1, 2, and 5 years, respectively. CONCLUSION: Fenestrated endovascular aneurysm repair using the Anaconda stent-graft system demonstrates high technical success and mid-term freedom from TVI. Extended intra-aortic stent protrusion and sealing length, significantly impact TVI adversely. Optimizing bridging stent geometry may reduce re-intervention rates and improve outcomes in complex aortic repairs.Clinical ImpactThis study demonstrates that fenestrated endovascular aneurysm repair using the Anaconda custom-made fenestrated stent-graft system provides high technical success and durable mid-term target vessel stability in complex aortic aneurysm repair. Importantly, it identifies modifiable anatomical predictors-excessive intra-aortic bridging stent protrusion and increased sealing length-as independent risk factors for target vessel instability. These findings shift attention from device selection alone to precise geometric optimization of bridging stents during procedural planning and deployment. For clinicians, careful control of protrusion length and sealing configuration may reduce endoleaks and re-interventions. The innovation lies in linking quantitative vessel geometry to clinical outcomes, offering actionable parameters to improve durability in FEVAR.
引用
- Becker D, Karaolanis GI, Ali AA, et al. Geometrical Analysis of Target Vessel Instability After FEVAR With Anaconda Stent-Graft System. J Endovasc Ther. 2026. PMID: 41792886. doi:10.1177/15266028261424752
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。